The purpose of this research study is to (1) provide access to fenfluramine for patientswith intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety offenfluramine.
The purpose of this research study is to (1) provide access to fenfluramine for patients
with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of
fenfluramine.
Drug: Fenfluramine
The treatment plan for this Expanded Access Protocol is for patients with Dravet syndrome
who do not qualify for participation in one of the ongoing ZX008 (fenfluramine
hydrochloride) clinical trials.
Other Name: Fenfluramine Hydrochloride
Inclusion Criteria:
- Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all
available medications for seizures.
University of California, Los Angeles
Los Angeles, California, United States
Investigator: Shaun Hussain, MD
Contact: 310-206-4037
Angela Martinez
310-206-4037
angelamartinez@mednet.ucla.edu
Not Provided